Status:
COMPLETED
Lidocaine For Treatment of Post-operative Pain From Donor Sites Following Burn Injury.
Lead Sponsor:
University of Florida
Conditions:
Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Burn pain is known to be one the most severe forms of acute pain often requiring large amounts of narcotics in addition to other adjuvants. Topical lidocaine is effective for controlling pain in vario...
Detailed Description
Pain from burns is a severe form of acute pain that requires aggressive use of opioids. Even with the implementation of multiple modalities for analgesia, pain from skin debridements and grafting proc...
Eligibility Criteria
Inclusion
- Adult patients who have suffered second to third degree burns requiring a single split thickness skin graft surgery.
- Donor sites will be between 3-15% TBSA.
Exclusion
- Patients who have history of chronic pain,
- opioid abuse history,
- major renal and/or liver dysfunction,
- history of seizures or major neurologic deficiencies,
- allergy to local anesthetics,
- reported allergy to hydromorphone,
- pregnancy, or
- currently have other injuries that significantly contribute to pain (i.e. multi-trauma patients) will be excluded from the study.
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 14 2017
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT02229578
Start Date
September 1 2014
End Date
November 14 2017
Last Update
July 1 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Shands Hospital, University of Florida
Gainesville, Florida, United States, 32601
2
Shands Hospital
Gainesville, Florida, United States, 32603